Prophylactic intrapartum amnioinfusion: a controlled retrospective study of 135 cases

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Neonatal Care

Background:

• Oligohydramnios and particulate meconium-stained amniotic fluid are associated with adverse perinatal outcomes.
• Intrapartum amnioinfusion (AI) is a procedure to instill fluid into the amniotic cavity during labor.
• The potential benefits of prophylactic AI in these specific conditions require further investigation.

Purpose of the Study:

• To evaluate the efficacy of intrapartum prophylactic amnioinfusion (AI) in managing oligohydramnios.
• To assess the impact of AI on outcomes in cases of particulate meconium-stained amniotic fluid.
• To determine if AI can reduce adverse perinatal events in high-risk pregnancies.

Main Methods:

• A prospective study involving 4031 deliveries from March 1993 to June 1995.
• Inclusion criteria: oligohydramnios (amniotic fluid index < 5 cm) or particulate meconium-stained amniotic fluid.
• Comparison with historical control groups matched for key demographic and obstetric variables.

Main Results:

• A significant reduction in cesarean sections was observed in the oligohydramnios group receiving AI (11.3% vs. 24.5%).
• The meconium-stained fluid group with AI showed a significant decrease in assisted deliveries for fetal distress (12.5% vs. 23.43%).
• No significant difference was found in the incidence of meconium below the vocal cords (1.6% vs. 9.4%) or other adverse effects.

Conclusions:

• Intrapartum amnioinfusion is technically feasible and safe for both mothers and neonates.
• Prophylactic AI appears beneficial in reducing cesarean rates for oligohydramnios.
• AI may decrease interventions for fetal distress in cases of meconium-stained fluid, warranting further prospective studies.